Press release
Rising Prevalence Of Cancer Drives G-CS Market Growth Driver: Leading Transformation in the G-CSF (Granulocyte Colony Stimulating Factors) Market in 2025
G-CSF (Granulocyte Colony Stimulating Factors)
The escalating incidence of cancer is a significant impetus propelling the expansion of the G-CSF (granulocyte colony stimulating factor) market. Recognized as the second primary reason for death, globally 1 in 6 deaths can be attributed to cancer. For example, data from the American Cancer Society, a voluntary health organization committed to cancer eradication in the USA, in January 2023 predicted 1,958,310 new cancer cases and 609,820 cancer-related deaths to take place in the USA in 2023. G-CSF (granulocyte colony stimulating factor) represents a type of growth factor that generates white blood cells in the bone marrow, thereby lowering the chances of infection and sepsis. Among cancer patients, G-CSF facilitates faster recovery and lessens mortality associated with neutropenia following chemotherapy for cancer. It can also curb infections post certain cancer treatments. Hence, the escalating incidence of cancer is projected to spur the expansion of the G-CSF (granulocyte colony stimulating factor) market.
Get Your G-CSF (Granulocyte Colony Stimulating Factors) Market Report Here:
https://www.thebusinessresearchcompany.com/report/g-csf-global-market-report
What is the projected compound annual growth rate (CAGR) of the g-csf (granulocyte colony stimulating factors) market from 2025 to 2034, and what factors influence it?
Recent years have seen a consistent expansion in the G-CSF (granulocyte colony stimulating factors) market. It's projected to swell from $5.5 billion in 2024 to $5.72 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.9%. This growth trend during the historical period can be linked to several factors including a surge in cancer cases, robust economic expansion in developing markets, augmented healthcare spending, elevated R&D expenditure within the pharmaceutical sector, and governmental initiatives.
The market for G-CSF (granulocyte colony stimulating factors) is predicted to experience substantial growth in the upcoming years, expanding to $7.19 billion in 2029 with a compound annual growth rate (CAGR) of 5.9%. This expansion during the forecast period is due to factors such as the rising prevalence of cancer, growing demand for prophylaxis granulocyte colony-stimulating factor (g-CSF), augmented healthcare spending, potential growth of upcoming economies, technological progress and widespread presence of biosimilar drugs. Significant trends anticipated during this period include hefty investment in research & development for cultivating effective and novel drugs, heightened focus on mergers and acquisitions to fuel growth, forming strategic alliances, evolution in new drug developments, and redirecting endeavors into manufacturing biosimilars for neutropenia treatment to boost revenue and diversify product portfolio.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3466&type=smp
How are the latest trends influencing the growth of the g-csf (granulocyte colony stimulating factors) market?
G-CSF (granulocyte colony-stimulating factor) market players are paying greater attention to strategic partnerships for both the development of innovative solutions and expansion of market footprint. This trend of cementing collaborations between companies, and also with academic and research organizations, through partnership or licensing agreements, has seen a surge in recent years. For instance, in 2022, Evive Biotech, a biopharmaceutical firm based in Singapore, teamed up with Germany's APOGEPHA in an exclusive, long-term license pact for commercializing Efbemalenograstim alfa (F-627) in Germany and Switzerland. This product, F-627, is an innovative dimeric G-CSF long-acting fusion protein that does not require pegylation.
What are the major segments of the g-csf (granulocyte colony stimulating factors) market and their role in driving growth?
The G-CSF (granulocyte colony stimulating factors) market covered in this report is segmented -
1) By Type: Pegfilgrastim, Lenograstim, Filgrastim, Other Types
2) By Product: Tablet, Capsule, Other Products
3) By Application: Oncological Diseases, Blood Disorders, Chronic And Autoimmune Disorders, Other Applications
Subsegments:
1) By Pegfilgrastim: Pre-filled Syringes, Vial Formulations, Biosimilars Of Pegfilgrastim
2) By Lenograstim: Injectable Formulations, Vial Formulations, Combination Therapies
3) By Filgrastim: Injectable Formulations, Pre-filled Syringes, Biosimilars Of Filgrastim
4) By Other Types: Filgrastim-sndz (Biosimilar), Novel G-CSF Products In Development, Combination Therapies With Other Growth Factors
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3466
Which regions are key players in the growth of the g-csf (granulocyte colony stimulating factors) market?
North America was the largest region in the G-CSF (granulocyte colony-stimulating factors) market in 2024. The regions covered in the G-CS (granulocyte colony stimulating factors) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the key firms paving the way for growth in the g-csf (granulocyte colony stimulating factors) market?
Major companies operating in the G-CSF (granulocyte colony stimulating factors) market include Amgen Inc., Coherus Biosciences Inc., Sandoz, Biocon/Mylan, Teva Pharmaceuticals Inc., Chugai Pharma, Intalfarmaco Group, Pfizer, Sun Pharmaceutical Industries Limited, BeyondSpring Inc., Kyowa Hakko Kirin Co. Ltd, BioCad, Stada Arzneimittel, Dong-A Socio Group, Dr. Reddy's Laboratories, Celltrion Inc., Emcure Pharmaceuticals, Accord Healthcare UK, Intas Pharmaceuticals, Spectrum Pharmaceuticals, Apobiologix, Apotex Inc., Eurofarma Laboratórios, BIOPHARMA-MEA, NeoTX, AID Genomics Limited, GlaxoSmithKline plc, AstraZeneca, Merck Sharp & Dohme Corp., Julphar, Sanofi, Novo Nordisk A/S, Bayer, Kitov Pharma Limited, CureTech Ltd., Neopharma, Cipla.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3466&type=smp
What Is Covered In The G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report?
• Market Size Forecast: Examine the g-csf (granulocyte colony stimulating factors) market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the g-csf (granulocyte colony stimulating factors) market for a structured understanding.
• Key Players Overview: Analyze major players in the g-csf (granulocyte colony stimulating factors) market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the g-csf (granulocyte colony stimulating factors) market.
• Segment Contributions: Evaluate how different segments drive overall growth in the g-csf (granulocyte colony stimulating factors) market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the g-csf (granulocyte colony stimulating factors) market.
• Industry Challenges: Identify potential risks and obstacles affecting the g-csf (granulocyte colony stimulating factors) market.
• Competitive Landscape: Review strategic developments in the g-csf (granulocyte colony stimulating factors) market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Cancer Drives G-CS Market Growth Driver: Leading Transformation in the G-CSF (Granulocyte Colony Stimulating Factors) Market in 2025 here
News-ID: 3901781 • Views: …
More Releases from The Business Research Company
Emerging Innovations Set to Redefine the Sewer Rehabilitation Services Market La …
How Large Is the Sewer Rehabilitation Services Market Anticipated to Become by 2025?
The global market for sewer rehabilitation services has experienced robust expansion lately, projected to increase from a valuation of $42.38 billion in 2024 to $45.14 billion in the subsequent year, reflecting a compound annual growth rate (CAGR) of 6.5%. This historical upward trajectory is primarily fueled by several key factors: escalating levels of urbanization, the ever-aging condition of…
2025-2034 Sea Based C4ISR Market Outlook: Emerging Drivers, Growth Barriers, and …
What Market Size Will the Sea Based C4ISR Sector Reach by 2025?
The maritime C4ISR market experienced substantial expansion lately, projected to climb from a value of $3.0 billion in 2024 to $3.17 billion the following year, reflecting a compound annual growth rate of 5.7%. This upward trend observed over the historical period stems from several factors, including the intensification of naval modernization initiatives, escalating maritime security perils, augmentation in defense…
The Impact of Rapid Urbanization on the Ripening Culture Market: A Key Force Sha …
What Is the Forecasted Size of the Ripening Culture Market by 2025?
The market for ripening cultures has experienced substantial expansion lately, projected to increase from a valuation of $1.46 billion in 2024 to $1.57 billion a year later, demonstrating a consistent yearly growth rate (CAGR) of 7.7%. This upward trajectory during the past period stems from several key factors, including heightened demand for fermented dairy items, greater recognition of the…
Strong Demand Anticipated to Drive Recirculating Chillers Market Toward $2.76 Bi …
How Much Expansion Is Expected in the Recirculating Chillers Market by 2025?
The market encompassing recirculating chillers has seen swift expansion lately, projected to escalate from a value of $1.65 billion in 2024 to $1.83 billion by the ensuing year, reflecting an impressive compound annual growth rate (CAGR) of 11.2%. This upward trajectory during the historical timeframe stems from several factors, including the proliferation of automated systems in industrial procedures, escalating…
More Releases for Factors
Human Factors and Usability Engineering Services Market Key Players Analysis - H …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Human Factors and Usability Engineering Services Market"-, By Steps Involved (Summative Study, Contextual Analysis, Formative Study, Known Use Error Analysis, Use Risk Analysis, Submission Preparation, Design Process and Task Analysis), By Type of Research Method (Evaluation Research and Generative Research), Class of Medical Device Tested (Class I, Class II and Class III ), Industry Trends, and…
Factors Driving Animal Protein
Animal proteins, such as meat, eggs and milk, are complete proteins, which means that they provide all the essential amino acids that our body needs. Animal products provide the highest quality protein sources.
Animal Protein Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors.…
Rubber Hose Market: Forecast With Top Companies, Growth Factors, Classification, …
According to a new report published by Allied Market Research, titled, "Rubber Hose Market by Type (Natural Rubber (Latex) and Synthetic Rubber), Pressure Rating (Low, Medium, and High), Application (Home, Commercial, Industrial, and Municipal), and End Use Industry (Oil & Gas, Automotive, Hydraulic, Agriculture, Food & Beverages, Chemicals, Infrastructure, Mining, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026". The report has offered an all-inclusive analysis of the global Rubber…
Articulated Hauler Market | Risk Factors, Growth Strategies | Market Driving Fac …
Snapshot of Articulated Hauler Market:
Articulated hauler, also known as articulated dump truck or ADT, is a heavy-duty equipment used for the transportation of loads in rough terrains. Generally utilized as a dump truck, articulated hauler primarily has two units – a tractor and a hauler or dump body.
Construction industry heavily relies on temporary works wherein equipment hire continues to remain at the centerstage. Considering the cost-intensive nature of…
Rolling Stock Market | Risk Factors, Growth Strategies | Market Driving Factors, …
Industrial Analysis of Global Rolling Stock Market:
The term Rolling stock originally referred to any vehicles that move on a railway. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Rolling Stock Report by Material, Application, and Geography.
Global Rolling Stock Market report provide in-depth overview of global industry with Major application, types and business players like CRRC,…
Apixaban Market | Risk Factors, Growth Strategies | Market Driving Factors, Fore …
The Apixaban Market report provides detailed profile assessments and current scenario revenue projections for the most promising industry participants. The Global Apixaban Industry report focuses on the latest trends in the Global and regional spaces on all the significant components, including the capacity, Market Players: Pfizer, Medichem, Polpharma, Beijing Cooperate Pharmaceutical, Centaur Pharmaceutical and more….
Get Exclusive Sample of Report on Apixaban market having 100 pages, profiling more than TOP…
